Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,732 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Studying the Humoral Response against SARS-CoV-2 in Cuban COVID-19 Recovered Patients.
Orosa Vázquez I, Díaz M, Zúñiga Rosales Y, Amada K, Chang J, Relova Hernández E, Tundidor Y, Roblejo Balbuena H, Monzón G, Torres Rives B, Noa Romero E, Carrillo Valdés D, Valdivia Álvarez I, Delahanty Fernández A, Díaz C, Solozabal J, Gil M, Sánchez B, Rojas G, Marcheco B, Carmenate T. Orosa Vázquez I, et al. Among authors: chang j. J Immunol Res. 2024 Sep 25;2024:7112940. doi: 10.1155/2024/7112940. eCollection 2024. J Immunol Res. 2024. PMID: 39359695 Free PMC article.
Enzyme-linked immunosorbent assay for quantitative determination of capsular polysaccharide production in Streptococcus pneumoniae clinical isolates.
Cruz-Leal Y, Menéndez T, Coizeau E, Espinosa RR, Canaan L, Blanco F, Carmenate T, Chang J, Quiñones D, Tamargo I, Cremata J, Verez-Bencomo V, Guillén G. Cruz-Leal Y, et al. Among authors: chang j. Biotechnol Appl Biochem. 2006 May;44(Pt 2):101-8. doi: 10.1042/BA20060007. Biotechnol Appl Biochem. 2006. PMID: 16420190
Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b.
Fernández-Santana V, Cardoso F, Rodriguez A, Carmenate T, Peña L, Valdés Y, Hardy E, Mawas F, Heynngnezz L, Rodríguez MC, Figueroa I, Chang J, Toledo ME, Musacchio A, Hernández I, Izquierdo M, Cosme K, Roy R, Verez-Bencomo V. Fernández-Santana V, et al. Among authors: chang j. Infect Immun. 2004 Dec;72(12):7115-23. doi: 10.1128/IAI.72.12.7115-7123.2004. Infect Immun. 2004. PMID: 15557635 Free PMC article.
First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia.
Chung HJ, Kondoh C, Bae WK, Tamada S, Matsubara N, Lee HJ, Mizuno R, Anai S, Kimura G, Tomita Y, Chang CH, Chang JW, Lin J, Perini RF, Molife LR, Powles T, Rini BI, Uemura H. Chung HJ, et al. Among authors: chang jw. Jpn J Clin Oncol. 2025 Jan 16:hyae182. doi: 10.1093/jjco/hyae182. Online ahead of print. Jpn J Clin Oncol. 2025. PMID: 39815637
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer.
Geyer CE Jr, Untch M, Huang CS, Mano MS, Mamounas EP, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, D'Hondt V, Conlin AK, Guarneri V, Wapnir IL, Jackisch C, Arce-Salinas C, Fasching PA, DiGiovanna MP, Crown JP, Wuelfing P, Shao Z, Rota Caremoli E, Bonnefoi HR, Hennessy BT, Stamatovic L, Castro-Salguero H, Brufsky AM, Knott A, Siddiqui A, Lambertini C, Boulet T, Nyawira B, Restuccia E, Loibl S; KATHERINE Study Group. Geyer CE Jr, et al. N Engl J Med. 2025 Jan 16;392(3):249-257. doi: 10.1056/NEJMoa2406070. N Engl J Med. 2025. PMID: 39813643 Clinical Trial.
21,732 results
You have reached the last available page of results. Please see the User Guide for more information.